Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-way crossover bioavailability and food-effect study of lusutrombopag 1‑mg and 4‑mg tablets in healthy males
jRCT2080224618Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of lusutrombopag in Thrombocytopenia, sponsored by Shionogi & Co., Ltd. Primary endpoint: Primary pharmacokinetic parameters of lusutrombopag. Started Mar 2019; status: completed.
02
Drugs
lusutrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on jRCT2080224618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224618.